CLOV vs NRXS · rev $1.37B vs rev $2.7M
Clover Health Investments Corp (CLOV) versus Neuraxis, Inc. (NRXS) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Neuraxis, Inc. (NRXS) is a biotechnology company listed on AMEX.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported NRXS revenue for 2024-12-31 was $2.7M. Net income was -$8.2M. Revenue was up 9.2% from 2023-12-31 to 2024-12-31. NRXS currently screens at market cap $83.1M.
CLOV currently screens at market cap $1.55B. NRXS currently screens at market cap $83.1M.
Not investment advice. Open the CLOV and NRXS stock pages for the full models.
Not investment advice.